- Report
- July 2025
- 50 Pages
Global
From €2326EUR$2,650USD£1,996GBP
Azacytosine is a type of oncology drug used to treat certain types of cancer. It is a nucleoside analog, meaning it is a synthetic version of a naturally occurring nucleoside. Azacytosine works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma.
Azacytosine is available in both oral and intravenous forms. It is typically used in combination with other chemotherapy drugs, such as doxorubicin and cyclophosphamide. Common side effects of azacytosine include nausea, vomiting, hair loss, and fatigue.
The azacytosine market is highly competitive, with several major players. These include Bristol-Myers Squibb, Merck, Pfizer, and Novartis. These companies are constantly developing new formulations and delivery systems to improve the efficacy and safety of azacytosine. Additionally, generic versions of azacytosine are available, allowing for more affordable treatment options.
In the azacytosine market, there are also several smaller companies, such as Spectrum Pharmaceuticals, Cephalon, and Teva Pharmaceuticals. These companies are focused on developing new formulations and delivery systems for azacytosine, as well as providing generic versions of the drug. Show Less Read more